Protective Effect of Toll-Like Receptor 4 Inhibitor TAK-242 on Kidney in Rats with Diabetic Nephropathy

周静,魏昕,曾艳,杨柳,李秋月,王瑜,罗来敏
DOI: https://doi.org/10.3969/j.issn.1006-6187.2015.12.015
2015-01-01
Abstract:Objective To explore the protective effect of TAK-242 ,a selective inhibitor of toll-like receptor 4 (TLR4) ,on kidney in diabetic rats and its possible mechanism. Methods A total of 60 healthy male SD rats were selected and randomly divided into three groups :normal control group (NC ,n=20) ,diabetic nephropathy model group (M ,n=20) and TAK-242 treatment group (TAK-242 ,n=20). The diabetic nephropathy rat model was established by one time injection of 60 mg/kg streptozotocin intraperitoneally. Body weight ,blood glucose ,24-hour urine protein ,serum creatinine (Scr) and plasma albumin were measured at 4 and 8 weeks after modeling. Protein expression levels of human nuclear factorκb inhibitor protein α (IκBα) ,NF-KBP65 ,TNF-α and monocyte chemoattractant protein 1 (MCP-1) were detected in fresh kidney tissue at the end of 8 weeks. Results Blood glucose ,Scr and 24-hour urine protein were significantly higher while body weight and plasma albumin were significantly lower in M and TAK-242 groups than in NC group (P<0.05). Scr[(69.8 ± 7.96)μmol/L] and 24-hour urine protein [(35.21 ± 8.06 ) mg/d] were significantly lower and plasma albumin level [(28.1 ± 6.9 ) g/L ] was significantly higher in TAK-242 group than in M group (P< 0.05). The content of NF-KBP65 and expression levels of TNF-αand MCP-1 were significantly lower while IκBα level was higher in TAK-242 group than in M group (P<0.05). Conclusion TAK-242 can protect the kidney in rats with diabetic nephropathy possibly through inhibition of NF-κB signal pathway.
What problem does this paper attempt to address?